Vr Adviser, LLC Reduced Holdings in Q1 2024

Vr Adviser, LLC

  • $1.17 Billion
  • Q1 2024
Stock Shares change Price Range Shares Held Trade History
CABA
Cabaletta Bio, Inc.

Healthcare
-1M
- 39.0%
$16.79 - $25.38 $16.8M - $25.4M
1.56M $26.7M
TERN
Terns Pharmaceuticals, Inc.

Healthcare
-1.09M
- 24.17%
$4.86 - $8.19 $5.28M - $8.9M
3.41M $22.4M
CELC
Celcuity Inc.

Healthcare
-916K
- 48.56%
$13.74 - $21.6 $12.6M - $19.8M
970K $21M
Spyre Therapeutics Inc
-201K
- 8.47%
N/A
2.17M $0
TSHA
Taysha Gene Therapies, Inc.

Healthcare
-1.41M
- 13.57%
$1.43 - $3.25 $2.02M - $4.59M
9M $25.8M
MRUS
Merus N.V.

Healthcare
-358K
- 16.67%
$28.03 - $51.82 $10M - $18.6M
1.79M $80.6M
Activity Summary
Buys All Purchases 23 New Holdings 9 Increased Positions 14 Sells All Sells 6 Reductions 6 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email